Dr. Gary Lyman, MPH, FASCO, FRCP, joins ASCO CEO Dr. Clifford A. Hudis to discuss biosimilars and ASCO’s recent statement on biosimilars published in the Journal of Clinical Oncology.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"ASCO in Action Podcast","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/action\/AiA-Podcast-Biosimilars-Lyman.mp3?dest-id=640682","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202205\/b4cd2a-3def-3794-929d24_800.png"},"title":"What Oncologists Need to Know about Biosimilars","link":"javascript:;","id":"item-5535668"}]
